Veracyte, Inc.
VCYT
Classement en actions
#4238
Veracyte, Inc. operates as a diagnostics company in the United States and... Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
Prix de l'action
$45.79
Capitalisation boursière
$3.68B
Changement (1 jour)
-0.92%
Changement (1 an)
31.78%
Pays
US
Échange Veracyte, Inc. (VCYT)
Catégorie
Healthcare
Historique du prix de l'action pour Veracyte, Inc. (VCYT)
Prix de clôture le plus élevé : $44.59 le 2026-10-01
Prix de clôture le plus bas : $12.82 le 2013-10-01
Prix de clôture le plus bas : $12.82 le 2013-10-01
Historique du prix de l'action de Veracyte, Inc. de 2013 à 2026
Performance annuelle du prix de l'action
| Année | Performance |
|---|---|
| 2026 (TTM) | -2.87% |
| 2025 | 3.85% |
| 2024 | 55.02% |
| 2023 | 1.26% |
| 2022 | -33.63% |
| 2021 | -25.42% |
| 2020 | 88.25% |
| 2019 | 137.21% |
| 2018 | 87.23% |
| 2017 | -13.42% |
| 2016 | 5.54% |
| 2015 | -8.13% |
| 2014 | -43.76% |
| 2013 | 0.00% |
Prix de l'action pour des entreprises similaires ou concurrentes
| Entreprise | Prix de l'action | Variation 1a% | Pays |
|---|---|---|---|
| $687.03 | 21.13% |
US
|
|
| $233.96 | 7.27% |
US
|
|
| $399.36 | 112.40% |
US
|
|
| $21.16 | 49.45% |
CN
|
|
| $175.98 | 20.64% |
US
|
